Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

1.

"Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis.

Rasi M, Künzler-Heule P, Schmid P, Semela D, Bruggmann P, Fehr J, Saxer S, Nicca D.

BMC Infect Dis. 2014 Sep 18;14(1):507. [Epub ahead of print]

PMID:
25231646
[PubMed - as supplied by publisher]
Free Article
2.

[In Process Citation].

Schärer V, Bruggmann P, Müllhaupt B, Fehr J.

Praxis (Bern 1994). 2014 Sep 1;103(19):1123-31. doi: 10.1024/1661-8157/a001782. German.

PMID:
25228574
[PubMed - in process]
3.

[Psychosocial aspects on the treatment of HIV-infection].

Battegay M, Haerry DH, Fehr J, Staehelin C, Wandeler G, Elzi L.

Ther Umsch. 2014 Aug;71(8):509-13. doi: 10.1024/0040-5930/a000545. German.

PMID:
25093317
[PubMed - in process]
4.

[Hepatitis B and C in HIV coinfection].

Fehr J, Schärer V, Hirzel C, Rauch A.

Ther Umsch. 2014 Aug;71(8):490-6. doi: 10.1024/0040-5930/a000542. German.

PMID:
25093314
[PubMed - in process]
5.

Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone.

Wang Q, Young J, Bernasconi E, Vernazza P, Calmy A, Cavassini M, Furrer H, Fehr J, Bucher HC, Battegay M; Swiss HIV Cohort Study.

HIV Clin Trials. 2014 May-Jun;15(3):92-103. doi: 10.1310/hct1503-92.

PMID:
24947533
[PubMed - indexed for MEDLINE]
6.

Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients.

Braun D, Rauch A, Durisch N, Eberhard N, Anagnostopoulos A, Ledergerber B, Metzner K, Böni J, Weber R, Fehr J.

HIV Med. 2014 Jun 4. doi: 10.1111/hiv.12166. [Epub ahead of print]

PMID:
24894776
[PubMed - as supplied by publisher]
7.

[Limitations of medicine:diagnosis and therapy of <<inflammatory>> back pain].

Scharer V, Hafner R, Ciurea A, Henning L, Somoskovi A, Weber R, Fehr J.

Praxis (Bern 1994). 2014 Mar 12;103(6):337-40. Review. German.

PMID:
24712089
[PubMed - indexed for MEDLINE]
8.

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.

Clotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I, Pokrovskiy V, Fehr J, Ortiz R, Saag M, Harris J, Brennan C, Fujiwara T, Min S; ING114915 Study Team.

Lancet. 2014 Jun 28;383(9936):2222-31. doi: 10.1016/S0140-6736(14)60084-2. Epub 2014 Apr 1.

PMID:
24698485
[PubMed - indexed for MEDLINE]
9.

Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases.

Grankvist A, Andersson PO, Mattsson M, Sender M, Vaht K, Höper L, Sakiniene E, Trysberg E, Stenson M, Fehr J, Pekova S, Bogdan C, Bloemberg G, Wennerås C.

Clin Infect Dis. 2014 Jun;58(12):1716-22. doi: 10.1093/cid/ciu189. Epub 2014 Mar 18.

PMID:
24647019
[PubMed - in process]
10.

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.

Hasse B, Walker AS, Fehr J, Furrer H, Hoffmann M, Battegay M, Calmy A, Fellay J, Di Benedetto C, Weber R, Ledergerber B; Swiss HIV Cohort Study.

Antimicrob Agents Chemother. 2014 Apr;58(4):2363-8. doi: 10.1128/AAC.01868-13. Epub 2014 Feb 10.

PMID:
24514096
[PubMed - in process]
11.

Reply: To PMID 23892243.

Conen A, Wang Q, Fehr J.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):e157-8. doi: 10.1097/QAI.0000000000000088. No abstract available.

PMID:
24346643
[PubMed - indexed for MEDLINE]
12.

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.

Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Pfyffer G, Ruef C, Fehr J, Zbinden R, Calandra T, Bille J.

Clin Microbiol Infect. 2014 Jul;20(7):698-705. doi: 10.1111/1469-0691.12440. Epub 2013 Dec 12.

PMID:
24188136
[PubMed - in process]
13.

Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study.

Conen A, Wang Q, Glass TR, Fux CA, Thurnheer MC, Orasch C, Calmy A, Bernasconi E, Vernazza P, Weber R, Bucher HC, Battegay M, Fehr J.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):472-8. doi: 10.1097/QAI.0b013e3182a61ea9.

PMID:
23892243
[PubMed - indexed for MEDLINE]
14.

Paracorporeal lung assist device: an innovative surgical strategy for bridging to lung transplant in an infant with severe pulmonary hypertension caused by alveolar capillary dysplasia.

Boston US, Fehr J, Gazit AZ, Eghtesady P.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):e42-3. doi: 10.1016/j.jtcvs.2013.06.014. Epub 2013 Jul 18. No abstract available.

PMID:
23871141
[PubMed - indexed for MEDLINE]
15.

Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.

Aebi-Popp K, Mulcahy F, Glass TR, Rudin C, Martinez de Tejada B, Bertisch B, Fehr J, Grawe C, Scheibner K, Rickenbach M, Hoesli I, Thorne C; European Collaborative Study in EuroCoord; Swiss Mother & Child HIV Cohort Study.

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):58-65. doi: 10.1097/QAI.0b013e3182a334e3.

PMID:
23842074
[PubMed - indexed for MEDLINE]
16.

Acute care of pediatric patients with sickle cell disease: a simulation performance assessment.

Burns TL, DeBaun MR, Boulet JR, Murray GM, Murray DJ, Fehr JJ.

Pediatr Blood Cancer. 2013 Sep;60(9):1492-8. doi: 10.1002/pbc.24558. Epub 2013 Apr 30.

PMID:
23633232
[PubMed - indexed for MEDLINE]
17.

Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.

Gallant JE, Koenig E, Andrade-Villanueva J, Chetchotisakd P, DeJesus E, Antunes F, Arastéh K, Moyle G, Rizzardini G, Fehr J, Liu Y, Zhong L, Callebaut C, Szwarcberg J, Rhee MS, Cheng AK.

J Infect Dis. 2013 Jul;208(1):32-9. doi: 10.1093/infdis/jit122. Epub 2013 Mar 26.

PMID:
23532097
[PubMed - indexed for MEDLINE]
Free Article
18.

HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis.

Fenner L, Egger M, Bodmer T, Furrer H, Ballif M, Battegay M, Helbling P, Fehr J, Gsponer T, Rieder HL, Zwahlen M, Hoffmann M, Bernasconi E, Cavassini M, Calmy A, Dolina M, Frei R, Janssens JP, Borrell S, Stucki D, Schrenzel J, Böttger EC, Gagneux S; Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups.

PLoS Genet. 2013;9(3):e1003318. doi: 10.1371/journal.pgen.1003318. Epub 2013 Mar 7.

PMID:
23505379
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prosthetic valve endocarditis caused by Propionibacterium species successfully treated with coadministered rifampin: report of two cases.

Braun DL, Hasse BK, Stricker J, Fehr JS.

BMJ Case Rep. 2013 Jan 25;2013. pii: bcr2012007204. doi: 10.1136/bcr-2012-007204.

PMID:
23355561
[PubMed - indexed for MEDLINE]
20.

Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study.

Boillat-Blanco N, Darling KE, Taffe P, Osih R, Strahm C, Adami M, Elzi L, Daou S, Fehr J, Wandeler G, Cavassini M.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):180-9. doi: 10.1097/QAI.0b013e31827b626a.

PMID:
23187939
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk